ID

21083

Beschreibung

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00448591

Link

https://clinicaltrials.gov/show/NCT00448591

Stichworte

Versionen (1)
  1. 09.04.17 09.04.17 -
Hochgeladen am

9. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer DRKS00003642 NCT00448591

Englisch

Eligibility Breast Cancer NCT00448591

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients, >=18 years of age;
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
Beschreibung

adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [2]
C0861355
UMLS CUI [3]
C1697918
candidates for chemotherapy.
Beschreibung

chemotherapy candidate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332149
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy for metastatic or locally recurrent breast cancer;
Beschreibung

previous chemotherapy for metastatic or locally recurrent breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0205156
concomitant hormonal therapy for metastatic or locally recurrent disease;
Beschreibung

concomitant hormonal therapy for metastatic or locally recurrent breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0279025
UMLS CUI [2,3]
C0521115
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
Beschreibung

concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [1,4]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C3853888
UMLS CUI [2,3]
C0338204
UMLS CUI [2,4]
C0521115
previous radiotherapy for treatment of metastatic disease;
Beschreibung

previous radiotherapy of metastatic breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0205156
evidence of cns metastases.
Beschreibung

breast cancer with cns metastases

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C0686377
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT00448591

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients, >=18 years of age;
boolean
C0001779 (UMLS CUI [1])
adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic
Item
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
boolean
C0858252 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0861355 (UMLS CUI [2])
C1697918 (UMLS CUI [3])
chemotherapy candidate
Item
candidates for chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy for metastatic or locally recurrent breast cancer
Item
previous chemotherapy for metastatic or locally recurrent breast cancer;
boolean
C0278493 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
concomitant hormonal therapy for metastatic or locally recurrent breast cancer
Item
concomitant hormonal therapy for metastatic or locally recurrent disease;
boolean
C0278493 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0521115 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0521115 (UMLS CUI [2,3])
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer
Item
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
boolean
C0278493 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0521115 (UMLS CUI [1,4])
C1697918 (UMLS CUI [2,1])
C3853888 (UMLS CUI [2,2])
C0338204 (UMLS CUI [2,3])
C0521115 (UMLS CUI [2,4])
previous radiotherapy of metastatic breast cancer
Item
previous radiotherapy for treatment of metastatic disease;
boolean
C1697918 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
breast cancer with cns metastases
Item
evidence of cns metastases.
boolean
C1697918 (UMLS CUI [1,1])
C0686377 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video